Adjuvant Exemestane With Ovarian Suppression in Premenopausal Breast Cancer: Long-Term Follow-Up of the Combined TEXT and SOFT TrialsOlivia Pagani, Prudence A. Francis, Barbara Walley et al.|Journal of Clinical Oncology|2022Cited by 159
Microwave ablation of liver metastases to overcome the limitations of radiofrequency ablationAnna Maria Ierardi, Gianpaolo Carrafiello, Chiara Floridi et al.|La radiologia medica|2013Cited by 71
Efficacy of Metronomic Oral Vinorelbine, Cyclophosphamide, and Capecitabine vs Weekly Intravenous Paclitaxel in Patients With Estrogen Receptor–Positive, <i>ERBB2</i>-Negative Metastatic Breast CancerElisabetta Munzone, L. J. Blacher, Meredith M. Regan et al.|JAMA Oncology|2023Cited by 37
Long-term follow-up of rituximab plus bendamustine and cytarabine in older patients with newly diagnosed MCLMaria Chiara Tisi, Carlo Visco, Caterina Stelitano et al.|Blood Advances|2023Cited by 23
Bcl-6 protein expression, and not the germinal centre immunophenotype, predicts favourable prognosis in a series of primary nodal diffuse large B-cell lymphomas: A single centre experienceSilvia Uccella, Carlo Capella, Claudia Placidi et al.|Leukemia & lymphoma/Leukemia and lymphoma|2008Cited by 22